阿尔茨海-话题@MedSci

#阿尔茨海#

755篇内容 | 3798人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1817964, encodeId=51bd181e96472, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Sci Rep：【世界阿尔茨海默病日】口服药物，或破阿尔茨海默症治疗僵局, objectType=article, longId=179810, objectId=7a7e1e9810fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a7e1e9810fe, replyNumber=0, likeNumber=72, createdTime=2020-04-16, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a7e1e9810fe, moduleTitle=Sci Rep：【世界阿尔茨海默病日】口服药物，或破阿尔茨海默症治疗僵局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a7e1e9810fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817971, encodeId=b75a181e9714f, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=卫材中国积极参与“第二届阿尔茨海默病月记忆健步行大型倡导活动”, objectType=article, longId=181519, objectId=99ba181519c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99ba181519c2, replyNumber=0, likeNumber=74, createdTime=2020-02-28, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99ba181519c2, moduleTitle=卫材中国积极参与“第二届阿尔茨海默病月记忆健步行大型倡导活动”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99ba181519c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818020, encodeId=1e151818020b8, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=2020EAN学术热点回顾阿尔茨海默病诊断新突破, objectType=article, longId=195608, objectId=df2c19560844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2c19560844, replyNumber=0, likeNumber=43, createdTime=2020-12-17, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2c19560844, moduleTitle=2020EAN学术热点回顾阿尔茨海默病诊断新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2c19560844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817962, encodeId=4de5181e9624a, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发, objectType=article, longId=179448, objectId=9f5b1e9448be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5b1e9448be, replyNumber=0, likeNumber=55, createdTime=2020-01-09, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5b1e9448be, moduleTitle=阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5b1e9448be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817973, encodeId=8014181e973e8, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Biogen的aducanumab治疗阿尔茨海默氏病符合III期试验终点, objectType=article, longId=181870, objectId=66f71818e0a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66f71818e0a7, replyNumber=0, likeNumber=85, createdTime=2020-08-29, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66f71818e0a7, moduleTitle=Biogen的aducanumab治疗阿尔茨海默氏病符合III期试验终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66f71818e0a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817998, encodeId=313e181e998bf, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Neurology：阿尔茨海默病患者出血性和缺血性卒中风险, objectType=article, longId=186517, objectId=409418651e31, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=409418651e31, replyNumber=0, likeNumber=81, createdTime=2020-06-15, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=409418651e31, moduleTitle=Neurology：阿尔茨海默病患者出血性和缺血性卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=409418651e31)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817996, encodeId=58d7181e996ee, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Nature：阿尔茨海默病患者脑脊液惊现免疫T细胞！, objectType=article, longId=186300, objectId=d8441863004e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8441863004e, replyNumber=0, likeNumber=56, createdTime=2020-11-24, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8441863004e, moduleTitle=Nature：阿尔茨海默病患者脑脊液惊现免疫T细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8441863004e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817975, encodeId=3022181e9752a, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=创新药“九期一”有条件批准上市！用于轻至中度阿尔茨海默病, objectType=article, longId=182295, objectId=1b7b1822954e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b7b1822954e, replyNumber=0, likeNumber=84, createdTime=2020-06-11, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b7b1822954e, moduleTitle=创新药“九期一”有条件批准上市！用于轻至中度阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b7b1822954e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817944, encodeId=0114181e9445b, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=新设备可通过血液快速确诊阿尔茨海默病, objectType=article, longId=174378, objectId=8d2f1e437888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d2f1e437888, replyNumber=0, likeNumber=49, createdTime=2019-07-02, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d2f1e437888, moduleTitle=新设备可通过血液快速确诊阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d2f1e437888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817960, encodeId=791c181e960e5, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Mol Psychaitr：颠覆认知！妊娠期间母亲高脂饮食可以预防后代阿尔茨海默症, objectType=article, longId=178436, objectId=60f41e843607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f41e843607, replyNumber=0, likeNumber=77, createdTime=2019-11-12, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f41e843607, moduleTitle=Mol Psychaitr：颠覆认知！妊娠期间母亲高脂饮食可以预防后代阿尔茨海默症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f41e843607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817947, encodeId=5ab2181e947ad, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=JAMA: 打破宿命论！健康的生活方式可以抵消阿尔茨海默症的遗传风险, objectType=article, longId=175648, objectId=d4af1e5648b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4af1e5648b9, replyNumber=0, likeNumber=115, createdTime=2020-05-10, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4af1e5648b9, moduleTitle=JAMA: 打破宿命论！健康的生活方式可以抵消阿尔茨海默症的遗传风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4af1e5648b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818009, encodeId=fb81181800950, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Biogen以27亿美元与基因编辑公司Sangamo签署协议，再次在阿尔茨海默氏病领域巨额投资, objectType=article, longId=189183, objectId=0b3318918384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3318918384, replyNumber=0, likeNumber=99, createdTime=2020-04-23, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3318918384, moduleTitle=Biogen以27亿美元与基因编辑公司Sangamo签署协议，再次在阿尔茨海默氏病领域巨额投资, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3318918384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817986, encodeId=eb99181e986a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为, objectType=article, longId=184027, objectId=968518402e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=968518402e4c, replyNumber=0, likeNumber=54, createdTime=2020-11-02, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=968518402e4c, moduleTitle=初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=968518402e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817999, encodeId=deb8181e99973, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, objectType=article, longId=186520, objectId=88ea186520c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88ea186520c4, replyNumber=0, likeNumber=99, createdTime=2020-03-14, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88ea186520c4, moduleTitle=Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88ea186520c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1818005, encodeId=045118180054e, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, objectType=article, longId=187845, objectId=85b418e84596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85b418e84596, replyNumber=0, likeNumber=70, createdTime=2020-04-16, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85b418e84596, moduleTitle=罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85b418e84596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817983, encodeId=9dfc181e98359, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=FDA批准：间充质干细胞治疗阿尔茨海默症的突破性临床试验, objectType=article, longId=183350, objectId=73a4183350de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73a4183350de, replyNumber=0, likeNumber=50, createdTime=2019-12-21, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73a4183350de, moduleTitle=FDA批准：间充质干细胞治疗阿尔茨海默症的突破性临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73a4183350de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817965, encodeId=0aa8181e96545, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Hypertension：血压变异性增大提示阿尔茨海默病认知恶化, objectType=article, longId=180005, objectId=a98a18000573, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a98a18000573, replyNumber=0, likeNumber=94, createdTime=2020-05-13, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a98a18000573, moduleTitle=Hypertension：血压变异性增大提示阿尔茨海默病认知恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a98a18000573)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817954, encodeId=13bf181e954f8, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=Ann Neurol：胰淀素作为2型糖尿病和阿尔茨海默病之间的潜在联系, objectType=article, longId=176870, objectId=d5bd1e6870b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5bd1e6870b2, replyNumber=0, likeNumber=93, createdTime=2019-12-01, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5bd1e6870b2, moduleTitle=Ann Neurol：胰淀素作为2型糖尿病和阿尔茨海默病之间的潜在联系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5bd1e6870b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817977, encodeId=fdd3181e977de, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=中国阿尔茨海默病新药GV-791引发巨大争议，理性对待为宜, objectType=article, longId=182356, objectId=67e21823561d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e21823561d, replyNumber=0, likeNumber=56, createdTime=2020-03-05, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e21823561d, moduleTitle=中国阿尔茨海默病新药GV-791引发巨大争议，理性对待为宜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e21823561d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1817976, encodeId=aad5181e9763d, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, objectTitle=药品上市许可人制度助力阿尔茨海默病创新药获批, objectType=article, longId=182334, objectId=a46f182334ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a46f182334ba, replyNumber=0, likeNumber=103, createdTime=2020-02-04, rootId=0, userName=12498da4m32(暂无昵称), userId=636e2500187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a46f182334ba, moduleTitle=药品上市许可人制度助力阿尔茨海默病创新药获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a46f182334ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阿尔茨海

2020-05-29

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Sci Rep：【世界阿尔茨海默病日】口服药物，或破阿尔茨海默症治疗僵局

2020-04-16

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

卫材中国积极参与“第二届阿尔茨海默病月记忆健步行大型倡导活动”

2020-02-28

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

2020EAN学术热点回顾阿尔茨海默病诊断新突破

2020-12-17

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发

2020-01-09

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Biogen的aducanumab治疗阿尔茨海默氏病符合III期试验终点

2020-08-29

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Neurology：阿尔茨海默病患者出血性和缺血性卒中风险

2020-06-15

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Nature：阿尔茨海默病患者脑脊液惊现免疫T细胞！

2020-11-24

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

创新药“九期一”有条件批准上市！用于轻至中度阿尔茨海默病

2020-06-11

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

新设备可通过血液快速确诊阿尔茨海默病

2019-07-02

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Mol Psychaitr：颠覆认知！妊娠期间母亲高脂饮食可以预防后代阿尔茨海默症

2019-11-12

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

JAMA: 打破宿命论！健康的生活方式可以抵消阿尔茨海默症的遗传风险

2020-05-10

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Biogen以27亿美元与基因编辑公司Sangamo签署协议，再次在阿尔茨海默氏病领域巨额投资

2020-04-23

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

初步调查排除了中国阿尔茨海默氏症药物开发者的学术造假行为

2020-11-02

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Theranexus宣布1b期研究结果，证明与多奈哌齐相比，其阿尔茨海默氏病候选药物THN201的药理学特性得到了扩展

2020-03-14

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

罗氏宣布其阿尔茨海默氏症单抗gantenerumab临床实验失败

2020-04-16

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

FDA批准：间充质干细胞治疗阿尔茨海默症的突破性临床试验

2019-12-21

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

Hypertension：血压变异性增大提示阿尔茨海默病认知恶化

2020-05-13

仁医06 (审核中...)

前往app查看评论内容

#阿尔茨海#

Ann Neurol：胰淀素作为2型糖尿病和阿尔茨海默病之间的潜在联系

2019-12-01

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

中国阿尔茨海默病新药GV-791引发巨大争议，理性对待为宜

2020-03-05

12498da4m32(暂无昵称) (审核中...)

前往app查看评论内容

#阿尔茨海#

药品上市许可人制度助力阿尔茨海默病创新药获批

2020-02-04

科室
- - 订阅+
  - 更多科室
工具
服务